Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Plasma proteomics uncovers divergent molecular signatures in ischemic stroke and intracerebral hemorrhage

  • del Río, Carmen
  • Penalba, Anna
  • Llucià-Carol, Laia|||0000-0002-7732-0665
  • Ezcurra Diaz, Garbiñe|||0000-0002-9511-3117
  • Guasch Jiménez, Marina|||0000-0001-6024-8348
  • Cullell, Natalia|||0000-0001-5118-1014
  • Serrano-Heras, Gemma|||0000-0001-9368-4832
  • Vives-Bauza, Cristòfol
  • Tur, Silvia
  • Urra, Xabier|||0000-0002-4763-5252
  • Castellanos, María del Mar|||0000-0003-3116-1352
  • Krupinski, Jerzy|||0000-0002-5136-8898
  • Freijo-Guerrero, Marimar
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Fernandez-Perez, Isabel|||0000-0002-9949-1393
  • Segura, Tomás|||0000-0003-3625-0987
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Montaner, Joan|||0000-0003-4845-2279
  • Núñez-Jurado, David
  • Fernández-Vega, Alejandro
  • Muiño, Elena|||0000-0001-5839-7328
  • Arias-Salazar, Lourdes
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
Timely differentiation between ischemic stroke (IS) and intracerebral hemorrhage (ICH) is critical for guiding appropriate acute management strategies. While neuroimaging is the diagnostic gold standard, its accessibility is often limited in urgent clinical settings. Blood biomarkers offer a promising, scalable diagnostic alternative; however, no validated panel is yet available for distinguishing stroke subtypes during the hyperacute phase. In a multicenter study, plasma samples were collected within 6 h of symptom onset. A total of 3,072 proteins were measured using Olink® proximity extension assays. We applied differential expression analysis, principal component analysis (PCA), partial least squares discriminant analysis (PLS-DA), and receiver operating characteristic (ROC) curve evaluation. To interpret the biological relevance of the findings, we conducted functional enrichment and protein-protein interaction (PPI) analyses. Among the 388 patients (344 IS, 44 ICH), 2,531 proteins were retained; 878 reached nominal significance (p.
Repositori Institucional UIB
Publication Artículo científico (JournalArticle)

Plasma proteomics uncovers divergent molecular signatures in ischemic stroke and intracerebral hemorrhage

  • Núñez-Jurado, D.
  • Fernández-Vega, A.
  • Del Río, C.
  • Penalba, A.
  • Llucià-Carol, L.
  • Muiño-Acuña, E.
  • Ezcurra-Díaz, G.
  • Guasch-Jiménez, M.
  • Cullell, N.
  • Serrano-Heras, G.
  • Arias-Salazar, L.
  • Vives-Bauza, C.
  • Tur, S.
  • Urra, X.
  • Castellanos, M.
  • Krupinski, J.
  • Freijo-Guerrero, M.
  • Jiménez-Conde, J.
  • Fernández-Pérez, I.
  • Segura, T.
  • Marti-Fabregas, J.
  • Férnandez-Cadenas, I.
  • Montaner, J.
[eng] Background: Timely differentiation between ischemic stroke (IS) and intracerebral hemorrhage (ICH) is critical for guiding appropriate acute management strategies. While neuroimaging is the diagnostic gold standard, its accessibility is often limited in urgent clinical settings. Blood biomarkers offer a promising, scalable diagnostic alternative; however, no validated panel is yet available for distinguishing stroke subtypes during the hyperacute phase. Methods: In a multicenter study, plasma samples were collected within 6 h of symptom onset. A total of 3,072 proteins were measured using Olink® proximity extension assays. We applied differential expression analysis, principal component analysis (PCA), partial least squares discriminant analysis (PLS-DA), and receiver operating characteristic (ROC) curve evaluation. To interpret the biological relevance of the findings, we conducted functional enrichment and protein-protein interaction (PPI) analyses. Results: Among the 388 patients (344 IS, 44 ICH), 2,531 proteins were retained; 878 reached nominal significance (p < 0.05), and 67 remained significant after multiple-testing correction (FDR-adjusted p < 0.05). Of these, 844 were overexpressed in ICH and 34 in IS. GFAP, a glial marker, emerged as the most discriminative biomarker for ICH versus IS (AUC = 0.887; sensitivity: 80%, specificity: 90%), followed by BCAN (AUC = 0.820), SNAP25 (AUC = 0.797), and SPOCK1 (AUC = 0.786). For IS, S100A12 (AUC = 0.677) and MNDA (AUC = 0.657) showed the best performance. Multivariate analyses confirmed the presence of distinct proteomic patterns, with enrichment revealing a significant overrepresentation of neurodevelopmental and synaptic pathways. In PPI networks, GFAP and LYN emerged as central hubs. Conclusion: This study reveals a robust plasma proteomic signature distinguishing IS from ICH within hours of onset. These results lay the groundwork for scalable, blood-based diagnostics to guide early stroke management when imaging is delayed or unavailable.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Plasma proteomics uncovers divergent molecular signatures in ischemic stroke and intracerebral hemorrhage

  • Núñez-Jurado, David
  • Fernández-Vega, Alejandro
  • del Río, Carmen
  • Penalba, Anna
  • Llucià-Carol, Laia
  • Muiño-Acuña, Elena
  • Ezcurra-Díaz, Garbiñe
  • Guasch, Marina
  • Cullel, Natalia
  • Serrano-Heras, Gemma
  • Arias-Salazar, Lourdes
  • Vives-Bauza, Cristófol
  • Tur, Silvia
  • Urra, Xabier
  • Castellanos, María del Mar
  • Krupinski, Jerzy
  • Freijo Guerrero, María del Mar
  • Jiménez-Conde, Jordi
  • Fernández-Pérez, Isabel
  • Segura, Tomás
  • Martí-Fàbregas, Joan
  • Fernández-Cadenas, Israel
  • Montaner, Joan
[Abstract] Background: Timely differentiation between ischemic stroke (IS) and intracerebral hemorrhage (ICH) is critical for guiding appropriate acute management strategies. While neuroimaging is the diagnostic gold standard, its accessibility is often limited in urgent clinical settings. Blood biomarkers offer a promising, scalable diagnostic alternative; however, no validated panel is yet available for distinguishing stroke subtypes during the hyperacute phase. Methods: In a multicenter study, plasma samples were collected within 6 h of symptom onset. A total of 3,072 proteins were measured using Olink® proximity extension assays. We applied differential expression analysis, principal component analysis (PCA), partial least squares discriminant analysis (PLS-DA), and receiver operating characteristic (ROC) curve evaluation. To interpret the biological relevance of the findings, we conducted functional enrichment and protein-protein interaction (PPI) analyses. Results: Among the 388 patients (344 IS, 44 ICH), 2,531 proteins were retained; 878 reached nominal significance (p < 0.05), and 67 remained significant after multiple-testing correction (FDR-adjusted p < 0.05). Of these, 844 were overexpressed in ICH and 34 in IS. GFAP, a glial marker, emerged as the most discriminative biomarker for ICH versus IS (AUC = 0.887; sensitivity: 80%, specificity: 90%), followed by BCAN (AUC = 0.820), SNAP25 (AUC = 0.797), and SPOCK1 (AUC = 0.786). For IS, S100A12 (AUC = 0.677) and MNDA (AUC = 0.657) showed the best performance. Multivariate analyses confirmed the presence of distinct proteomic patterns, with enrichment revealing a significant overrepresentation of neurodevelopmental and synaptic pathways. In PPI networks, GFAP and LYN emerged as central hubs. Conclusion: This study reveals a robust plasma proteomic signature distinguishing IS from ICH within hours of onset. These results lay the groundwork for scalable, blood-based diagnostics to guide early stroke management when imaging is delayed or unavailable., This work was funded by the National Institute of Health Carlos III (ISCIII) under the framework of Health Research Projects (PMP21/00165, PREVICTUS; and PI21/01158, ETNIAS) and co-funded by the European Union. D.N-J. was supported by a Río Hortega contract (CM23/00216) from the ISCIII. C.R. was supported by the applied research and innovation project POLIFENEV, co-funded by the European Union – Ministry of Finance and Civil Service – European Funds – Regional Government of Andalusia – Ministry of University, Research and Innovation.A.F-V. was supported by a contract funded through the CRESCENDO project (grant AC22/00005) from the ISCIII. This work was supported by project RD21/0006/0015 and RD24/0009/0007, funded by the ISCIII with public funding from the Cooperative Research Networks for Health Results (RICORS) RICORS-ICTUS.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Plasma proteomics uncovers divergent molecular signatures in ischemic stroke and intracerebral hemorrhage

  • Núñez Jurado, David
  • Fernández-Vega, Alejandro
  • Del Río, Carmen
  • Penalba, Anna
  • Llucià-Carol, Laia
  • Muiño-Acuña, Elena
  • Ezcurra-Díaz, Garbiñe
  • Guasch-Jiménez, Marina
  • Cullell, Natalia
  • Serrano-Heras, Gemma
  • Arias-Salazar, Lourdes
  • Vives-Bauza, Cristòfol
  • Tur, Silvia
  • Urra, Xabier
  • Castellanos, Mar
  • Krupinski, Jerzy
  • Freijo-Guerrero, Marimar
  • Jiménez-Conde, Jordi
  • Fernández-Pérez, Isabel
  • Segura, Tomás
  • Marti-Fabregas, Joan
  • Férnandez-Cadenas, Israel
  • Montaner, Joan
[Background] Timely differentiation between ischemic stroke (IS) and intracerebral hemorrhage (ICH) is critical for guiding appropriate acute management strategies. While neuroimaging is the diagnostic gold standard, its accessibility is often limited in urgent clinical settings. Blood biomarkers offer a promising, scalable diagnostic alternative; however, no validated panel is yet available for distinguishing stroke subtypes during the hyperacute phase., [Methods] In a multicenter study, plasma samples were collected within 6 h of symptom onset. A total of 3,072 proteins were measured using Olink® proximity extension assays. We applied differential expression analysis, principal component analysis (PCA), partial least squares discriminant analysis (PLS-DA), and receiver operating characteristic (ROC) curve evaluation. To interpret the biological relevance of the findings, we conducted functional enrichment and protein–protein interaction (PPI) analyses., [Results] Among the 388 patients (344 IS, 44 ICH), 2,531 proteins were retained; 878 reached nominal significance (p < 0.05), and 67 remained significant after multiple-testing correction (FDR-adjusted p < 0.05). Of these, 844 were overexpressed in ICH and 34 in IS. GFAP, a glial marker, emerged as the most discriminative biomarker for ICH versus IS (AUC = 0.887; sensitivity: 80%, specificity: 90%), followed by BCAN (AUC = 0.820), SNAP25 (AUC = 0.797), and SPOCK1 (AUC = 0.786). For IS, S100A12 (AUC = 0.677) and MNDA (AUC = 0.657) showed the best performance. Multivariate analyses confirmed the presence of distinct proteomic patterns, with enrichment revealing a significant overrepresentation of neurodevelopmental and synaptic pathways. In PPI networks, GFAP and LYN emerged as central hubs., [Conclusion] This study reveals a robust plasma proteomic signature distinguishing IS from ICH within hours of onset. These results lay the groundwork for scalable, blood-based diagnostics to guide early stroke management when imaging is delayed or unavailable., This work was funded by the National Institute of Health Carlos III (ISCIII) under the framework of Health Research Projects (PMP21/00165, PREVICTUS; and PI21/01158, ETNIAS) and co-funded by the European Union. D.N-J. was supported by a Río Hortega contract (CM23/00216) from the ISCIII. C.R. was supported by the applied research and innovation project POLIFENEV, co-funded by the European Union – Ministry of Finance and Civil Service – European Funds – Regional Government of Andalusia – Ministry of University, Research and Innovation.A.F-V. was supported by a contract funded through the CRESCENDO project (grant AC22/00005) from the ISCIII. This work was supported by project RD21/0006/0015 and RD24/0009/0007, funded by the ISCIII with public funding from the Cooperative Research Networks for Health Results (RICORS) RICORS-ICTUS., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Genetic Architecture of Ischaemic Strokes after COVID-19 Shows Similarities with Large Vessel Strokes

  • Llucià-Carol, Laia|||0000-0002-7732-0665
  • Muiño, Elena|||0000-0001-5839-7328
  • Cullell, Natalia|||0000-0001-5118-1014
  • Cárcel-Márquez, Jara|||0000-0002-6949-0699
  • Lledós, Miquel|||0000-0001-8832-789X
  • Gallego Fabrega, Cristina|||0000-0003-3229-5512
  • Martín-Campos, Jesús María|||0000-0003-0414-037X
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Aguilera-Simón, Ana|||0000-0003-1428-8212
  • Planas, Anna Maria|||0000-0002-6147-1880
  • DeDiego, Marta L.|||0000-0002-7888-7372
  • De Felipe, Alicia
  • Masjuan, Jaime|||0000-0003-1329-0943
  • García-Madrona, Sebastián
  • Segura, Tomás|||0000-0003-3625-0987
  • González-Villar, Esther
  • Serrano-Heras, Gemma|||0000-0001-9368-4832
  • Domínguez-Mayoral, Ana
  • Menéndez-Valladares, Paloma
  • Montaner, Joan|||0000-0003-4845-2279
  • Migeotte, Isabelle
  • Rahmouni, Souad
  • Darcis, Gilles|||0000-0001-8192-1351
  • Bernardo, D.|||0000-0002-2843-6696
  • Rojo, Silvia
  • Schulte, Eva C.|||0000-0003-3105-5672
  • Protzer, Ulrike|||0000-0002-9421-1911
  • Fricke, Lisa|||0000-0002-9268-0546
  • Winter, Christof|||0000-0002-0253-9056
  • Niemi, Mari E. K.
  • Cordioli, Mattia|||0000-0002-4872-0520
  • Delgado Martínez, María Pilar|||0000-0002-1628-4488
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
We aimed to analyse whether patients with ischaemic stroke (IS) occurring within eight days after the onset of COVID-19 (IS-COV) are associated with a specific aetiology of IS. We used SUPERGNOVA to identify genome regions that correlate between the IS-COV cohort (73 IS-COV cases vs. 701 population controls) and different aetiological subtypes. Polygenic risk scores (PRSs) for each subtype were generated and tested in the IS-COV cohort using PRSice-2 and PLINK to find genetic associations. Both analyses used the IS-COV cohort and GWAS from MEGASTROKE (67,162 stroke patients vs. 454,450 population controls), GIGASTROKE (110,182 vs. 1,503,898), and the NINDS Stroke Genetics Network (16,851 vs. 32,473). Three genomic regions were associated (p -value < 0.05) with large artery atherosclerosis (LAA) and cardioembolic stroke (CES). We found four loci targeting the genes PITX2 (rs10033464, IS-COV beta = 0.04, p -value = 2.3 × 10 -2, se = 0.02), previously associated with CES, HS6ST1 (rs4662630, IS-COV beta = -0.04, p -value = 1.3 × 10 -3, se = 0.01), TMEM132E (rs12941838 IS-COV beta = 0.05, p -value = 3.6 × 10 -4, se = 0.01), and RFFL (rs797989 IS-COV beta = 0.03, p -value = 1.0 × 10 -2, se = 0.01). A statistically significant PRS was observed for LAA. Our results suggest that IS-COV cases are genetically similar to LAA and CES subtypes. Larger cohorts are needed to assess if the genetic factors in IS-COV cases are shared with the general population or specific to viral infection.